LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY

Basaran, O.Dogan, V.Mert, G. O.Mert, K. U.Ozlek, B.Celik, O.Kayikciolu, M.2021-11-012021-11-0120190021-91501879-1484https://doi.org/10.1016/j.atherosclerosis.2019.06.618https://hdl.handle.net/11491/690287th Congress of the European-Atherosclerosis-Society (EAS) -- MAY 26-29, 2019 -- Maastricht, NETHERLANDS[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDYConference Object287E203E20310.1016/j.atherosclerosis.2019.06.618N/AWOS:000482110800616